{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morton Grove",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "89624",
      "recalling_firm": "Morton Grove Pharmaceuticals, Inc.",
      "address_1": "6451 Main St",
      "address_2": "",
      "postal_code": "60053-2633",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide USA and Puerto Rico",
      "recall_number": "D-0713-2022",
      "product_description": "Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.",
      "product_quantity": "",
      "reason_for_recall": "Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.",
      "recall_initiation_date": "20220221",
      "center_classification_date": "20220321",
      "termination_date": "20240806",
      "report_date": "20220309",
      "code_info": "Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23",
      "more_code_info": ""
    }
  ]
}